Article Details

Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the ...

Retrieved on: 2021-05-27 05:15:00

Tags for this article:

Click the tags to see associated articles and topics

Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the .... View article details on hiswai:

Excerpt

... setting due to multi-specific target binding, long half-life for sustained activity and highly scalable production, compared to monoclonal antibodies.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up